PecFent® is a nasally administrated spray which contains PecSys®. PecFent® is designed to optimise the absorption of fentanyl, matching drug absorption and clinical effect to the profile of a break through cancer pain episode experienced by cancer patients who are already receiving opioid analgesics for chronic pain.

Marketed by Kyowa Kirin in

Marketed by Kyowa Kirin International in

  • UK
  • France
  • Germany
  • Spain
  • Netherlands
  • Denmark
  • Finland
  • Norway
  • Sweden
  • Portugal